Accessibility Menu
CapsoVision logo

CapsoVision(NASDAQ) CV

Market Cap$344.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)+93%
5 YearN/A
1 Year+64%
1 Month+22%
$6.91
+2.07%
+0.14Today
After hours$6.92+$0.01 (+0.15%)
CapsoVision last closing stock price
MetricPriceDate
Last closeUSD 6.902026-08-06
CapsoVision stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.99%USD 6.702026-07-30
1 month+21.69%USD 5.672026-07-07
3 month-3.09%USD 7.122026-05-08
Year to date-35.45%USD 10.692025-12-31
1 year+63.51%USD 4.222025-08-06
Since inception+93.43%USD 3.502025-07-02

CapsoVision Financials at a Glance

Market Cap

$344.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$13.56M

Net Income (TTM)

-$26.97M

EPS (TTM)

-$0.57

P/E Ratio

-12.02

Dividend

$0.00

Beta (Volatility)

0.67 (Low)

Price

$6.91

Volume

69,631.184

Open

$6.70

Previous Close

$6.90

Daily Range

$6.55 - $7.00

52-Week Range

$3.43 - $15.37

Estimated Earnings Date

Aug 13, 2026

CV News

Foolcom-Featured.png

CapsoVision Revenue Jumps 17 Percent

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CapsoVision

CapsoVision makes tiny cameras that people swallow for medical checkups. These cameras take pictures of the digestive system from the inside. They help doctors find health problems without using long tubes.

Smart Cameras for the Gut

  • CapsoCam Plus: Single-use capsule that visualizes the small bowel (small intestine); accounts for 100% of revenue.
  • CapsoCam Colon: Future device designed to detect and measure polyps (growths) in the large intestine.
  • CapsoCloud: Web-based platform that lets doctors review intestine videos from any location.
  • CapsoView: Local software used to download and analyze data directly from the capsule.

Moving Beyond the Small Bowel

  • Received FDA (U.S. Food and Drug Administration) clearance in December 2024 for children to use diagnostic capsules.
  • Submitted an application for FDA Breakthrough Device Designation for early pancreatic cancer detection in November 2025.
  • Applied for FDA approval in December 2025 to add artificial intelligence to existing products.
  • Prioritized a second-generation colon capsule after meeting with the FDA in December 2025.

Technology That Sees Everything

CapsoVision holds over 140 patents for its unique imaging and artificial intelligence tools. These systems allow doctors to measure tissue abnormalities in three dimensions without invasive surgery.

A Look at the Numbers

  • Full-year revenue reached $13.6 million in 2025, up 15% from 2024.
  • Operating income reached $10.2 million in Q4 2025, improved from a $4.6 million loss in Q4 2024.
  • Net income was -$7.4 million in Q4 2025, worsened from a $4.6 million loss in Q4 2024.
  • International sales accounted for 21% of total revenue for the year ended December 31, 2025.
  • Free cash flow was -$12.7 million in Q4 2025, worsened from -$5.4 million in Q4 2024.

Evolution of Intestinal Imaging

CapsoVision is shifting from a small bowel diagnostic firm to an artificial intelligence imaging provider. Its focus on wire-free technology and remote monitoring addresses the growing demand for home-based healthcare.

AI Generated • May 8, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

99

CEO

Kang-Huai Wang

Website

capsovision.com

Headquarters

Saratoga, CA 95070, US

CV Financials

Key Financial Metrics (TTM)

Gross Margin

51.67%

Operating Margin

-11.01%

Net Income Margin

-198.87%

Return on Equity

126.84%

Return on Capital

-180.36%

Return on Assets

-103.96%

Earnings Yield

-8.32%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$344.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

49.96M

Volume

69.63K

Avg. Volume

146.55K

Financials (TTM)

Gross Profit

$7.01M

Operating Income

-$1.49M

EBITDA

-$26.65M

Operating Cash Flow

-$23.94M

Capital Expenditure

-$98.00K

Free Cash Flow

-$24.04M

Cash & ST Invst.

$17.93M

Total Debt

$788.00K

CapsoVision Performance Analysis

CapsoVision annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-12-31USD 9,752,850N/A
20242024-12-31USD 11,756,00020.5%
20252025-12-31USD 13,554,00015.3%
CapsoVision sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3019.1%
Q32025-09-306.7%
Q42025-12-3110.7%
Q12026-03-31-28.7%
CapsoVision annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-12-31USD -0.24N/A
20242024-12-31USD -0.4376.1%
20252025-12-31USD -0.5425.8%
CapsoVision sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3023.2%
Q32025-09-30-70.3%
Q42025-12-31-270.6%
Q12026-03-3176.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.79M

+0.3%

Gross Profit

$1.33M

-11.0%

Gross Margin

47.60%

N/A

Market Cap

$344.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.48M

N/A

Employees

99

N/A

Net Income

-$7.03M

-30.8%

EBITDA

-$6.94M

-32.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$17.93M

+307.8%

Total Debt

$788.00K

-31.7%

Accounts Receivable

$1.93M

+17.7%

Inventory

$3.49M

+14.9%

Long Term Debt

$362.00K

-54.1%

Short Term Debt

$426.00K

+16.7%

Return on Assets

-1.04%

N/A

Return on Invested Capital

-7.25%

N/A

Free Cash Flow

-$6.11M

-21.6%

Operating Cash Flow

-$6.07M

-21.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,715.71-0.00%
^DJIDJI
$53,946.95-0.01%
^IXICNASDAQ
$26,362.59-0.00%
BTCBitcoin
$64,490.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TTDThe Trade Desk
$17.67-0.07%
SPCXSpace Exploration Technologies
$114.92+0.06%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$26.93-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$72.03-0.01%

Questions About CV

What is the current price of CapsoVision?

CapsoVision is trading at $6.90 per share.

What is the 52-week range for CapsoVision?

Over the past 52 weeks, CapsoVision has traded between $3.43 and $15.37.

How much debt does CapsoVision have?

As of the most recent reporting period, CapsoVision reported total debt of $788.00K.

How much cash does CapsoVision have on hand?

CapsoVision reported $17.93M in cash and cash equivalents in its most recent financial results.

What is CapsoVision’s dividend yield?

CapsoVision does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services